Demonstration of p53 protein and TP53 gene mutations in oligodendrogliomas

European Journal of Cancer Part A

Volumn 32, Issue 13, 1996, Pages 2242-2248

  Hagel, C ^b   Laking, G ^b   Laas, R ^b   Scheil, S ^b   Jung, R ^b   Milde Langosch, K ^a   Stavrou, D K ^b  

^a UNIVERSITY OF HAMBURG   (Germany)

^b NONE

Author keywords

Oligodendrogliomas; p53 protein accumulation; TP53 gene mutation

Indexed keywords

PROTEIN P53;

ADULT; ARTICLE; CANCER RECURRENCE; DNA SEQUENCE; FEMALE; GENE MUTATION; GLIOMA; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; OLIGODENDROGLIOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ADULT; BRAIN NEOPLASMS; FEMALE; GENES, P53; HUMANS; IMMUNOENZYME TECHNIQUES; MALE; MIDDLE AGED; MUTATION; NEOPLASM PROTEINS; OLIGODENDROGLIOMA; POLYMERASE CHAIN REACTION; POLYMORPHISM, SINGLE-STRANDED CONFORMATIONAL; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0030473637     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0959-8049(96)00259-6     Document Type: Article

References (21)

1. 1. Levine AJ, Perry ME, Chang A, et al. The 1993 Walter Hubert lecture: the role of the p53 tumor-suppressor gene in tumorigenesis. Br J Cancer 1994, 69, 409-416.
2. 2. Newcomb EW, Madonia WJ, Pisharody S, Lang FF, Koslow M, Miller DC. A correlative study of p53 protein alteration and p53 gene mutation in glioblastoma multiforme. Brain Pathol 1993, 3, 229-235.
3. 3. Ohgaki H, Eibl RH, Wiestler OD, Yasargil MG, Newcomb EW, Kleihues P. TP53 mutations in nonastrocytic human brain tumors. Cancer Res 1991, 51, 6202-6205.
4. 4. Kros JM, Godschalk JJCJ, Krishnadath KK, van Eden CG. Expression of p53 in oligodendrogliomas. J Pathol 1993, 171, 285-290.
5. 5. Kleihues P, Burger PC, Scheithauer BW. Histological Typing of Tumours of the Central Nervous System, 2nd edition. Heidelberg, Springer-Verlag, 1993.
6. 6. Kiene P, Milde-Langosch K, Runkel M, Schulz M, Löning T. A simple and rapid technique to process formalin-fixed, paraffin-embedded tissues for the detection of viruses by the polymerase chain reaction. Virchows Arch A Pathol Anat Histopathol 1992, 420, 269-273.
7. 7. Mashiyama S, Murakami Y, Yoshimoto T, Sekiya T, Hayashi K. Detection of p53 gene mutations in human brain tumors by single-strand conformation polymorphism analysis of polymerase chain reaction products. Oncogene 1991, 6, 1313-1318.
8. 8. Milde-Langosch K, Albrecht K, Joram S, Schlechte H, Giessing M, Löning T. Presence and persistence of HPV infection and p53 mutation in cancer of the cervix uteri and the vulva. Int J Cancer 1995, 63, 639-645.
9. 9. Hagel C, Schwarz P, Laas R, Stavrou DK. Comparison of four proliferation markers and their significance for evaluation of tumor dignity in intracranial tumors. Int J Oncol 1995, 7, 107-113.
10. 10. Bögler O, Su Huang H-J, Kleihues P, Cavenee WK. The p53 gene and its role in human brain tumors. Glia 1995, 15, 308-327.
11. 11. Ellison DW, Steart PV, Bateman AC, Pickering RM, Palmer JD, Weller RO. Prognostic indicators in a range of astrocytic tumours: an immunohistochemical study with Ki-67 and p53 antibodies. J Neurol Neurosurg Psychiatry 1995, 59, 413-419.
12. 12. Hollstein M, Rice K, Greenblatt MS, et al. Database of p53 gene somatic mutations in human tumors and cell lines. Nucleic Acids Res 1994, 22, 3551-3555.
13. 13. Chung R, Whaley J, Kley N, et al. TTP53 gene mutations and 17p deletions in human astrocytomas. Genes Chromosom Cancer 1991, 3, 323-331.
14. 14. Saxena A, Clark WC, Robertson JT, Ikejiri B, Oldfield EH, Ali IU. Evidence for the involvement of a potential second tumor suppressor gene on chromosome 17 distinct from p53 in malignant astrocytomas. Cancer Res 1992, 52, 6716-6721.
15. 15. Tenan M, Colombo BM, Pollo B, Cajola L, Broggi G, Finocchiaro G. TP53 mutations and microsatellite analysis of loss of heterozygosity in malignant gliomas. Cancer Genet Cytogenet 1994, 74, 139-143.
16. 16. Koga H, Zhang S, Kumanishi T, et al. Analysis of p53 gene mutations in low- and high-grade astrocytomas by polymerase chain reaction-assisted single-strand conformation polymorphism and immunohistochemistry. Acta Neuropathol 1994, 87, 225-232.
17. 17. Lang FF, Douglas CM, Koslow M, Newcomb EW. Pathways leading to glioblastoma multiforme: a molecular analysis of genetic alterations in 65 astrocytic tumors. J Neurosurg 1994, 81, 427-436.
18. 18. Louis DN, von Deimling A, Chung RY, et al. Comparative study of p53 gene and protein alterations in human astrocytic tumors. J Neuropathol Exp Neurol 1993, 52, 31-38.
19. 19. Greenblatt MS, Bennett WP, Hollstein M, Harris CC. Mutations in the p53 tumor suppressor genes: clues to cancer etiology and molecular pathogenesis. Cancer Res 1994, 54, 4855-4878.
20. 20. Zhang W, Hu G, Esley E, Hester J, Deisseroth A. Altered conformation of the p53 protein in myeloid leukemia cells and mitogen-stimulated normal blood cells. Oncogene 1992, 7, 1645-1647.
21. 21. Oliner JD, Kinzler KW, Meltzer PS, George DL, Vogelstein B. Amplification of a gene encoding a p53-associated protein in human sarcomas. Nature 1992, 358, 80-83.